Winner Medical Co. Ltd. Class A

Winner Medical Co. Ltd. Class A

SSZSE:300888
29.46
CNY
-0.20
(-0.67%)
1.41EPS
21.95P/E
17.05BMarket Cap
Apr 28Next Earn

Total Valuation

CNY

As of September 30, 2026, Winner Medical Co. Ltd. Class A carries a market capitalization of 17.05B, placing it among publicly traded companies globally. Its enterprise value stands at 15.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap17.05B
Enterprise Value15.82B

Important Dates

Winner Medical Co. Ltd. Class A's next confirmed earnings release is scheduled for April 28, 2027.

Earnings Date4/28/2027

Share Statistics

As of September 30, 2026, Winner Medical Co. Ltd. Class A has 582.97M shares outstanding.

Shares Outstanding582.97M

Valuation Ratios

As of September 30, 2026, Winner Medical Co. Ltd. Class A trades at a trailing price-to-earnings ratio of 21.95. The price-to-sales ratio is 1.52, and the price-to-book ratio stands at 1.50.

PE Ratio21.95
PS Ratio1.52
PB Ratio1.50
P/TBV Ratio1.85

Enterprise Valuation

As of September 30, 2026, Winner Medical Co. Ltd. Class A trades at an EV/EBITDA multiple of 15.47 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.47 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 15.82B versus a market cap of 17.05B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.41
EV / EBITDA15.47
EV / EBIT15.47

Financial Position

As of September 30, 2026, Winner Medical Co. Ltd. Class A maintains a current ratio of 1.88, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.17, indicating elevated leverage, while an interest coverage ratio of 29.03 demonstrates strong ability to service its debt obligations.

Current Ratio1.88
Quick Ratio0.99
Debt / Equity25.17
Debt / EBITDA3.00
Interest Coverage29.03

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Winner Medical Co. Ltd. Class A posted a return on equity (ROE) of 6.78, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 5.48 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.21, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.05, useful for judging operating efficiency across full business cycles. The company generates approximately 709,449.96 in revenue per employee across its workforce of 15,855.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.75 indicates how many times Winner Medical Co. Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)6.78
Return on Assets (ROA)4.21
Return on Invested Capital (ROIC)5.48
Return on Capital Employed (ROCE)5.05
Revenue Per Employee709,449.96
Employee Count15,855.00
Inventory Turnover2.75

Taxes

CNY

Over the twelve months ended September 30, 2026, Winner Medical Co. Ltd. Class A recorded 192.23M in income tax expense. That works out to an effective tax rate of 18.92, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.02B, leaving 776.96M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax192.23M
Effective Tax Rate18.92

Stock Price Statistics

CNY

As of the close on November 17, 2026, Winner Medical Co. Ltd. Class A's stock has declined approximately 29.30% over the past 52 weeks. The 50-day moving average sits at 29.73, while the 200-day moving average is 31.02.

52-Week Price Change-29.30%
50-Day Moving Average29.73
200-Day Moving Average31.02

Income Statement

CNY

Over the twelve months ended September 30, 2026, Winner Medical Co. Ltd. Class A generated 11.25B in revenue and converted that into 776.96M in net income, yielding earnings per share of 1.41. EBITDA reached 1.02B, while operating income came in at 1.33B.

Revenue11.25B
Gross Profit5.34B
Operating Income1.33B
Pretax Income1.02B
Net Income776.96M
EBITDA1.02B
EBIT1.02B
Earnings Per Share (EPS)1.41

Balance Sheet

CNY

As of September 30, 2026, Winner Medical Co. Ltd. Class A holds 5.12B in cash and equivalents against 3.07B in total debt, resulting in a net debt position of 1.16B. Total book value stands at 11.39B, with working capital of 4.58B providing operational flexibility.

Cash & Cash Equivalents5.12B
Total Debt3.07B
Net Debt1.16B
Equity (Book Value)11.39B
Book Value Per Share19.55
Working Capital4.58B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-760.95M

Margins

Over the twelve months ended September 30, 2026, Winner Medical Co. Ltd. Class A posted a gross margin of 47.47, reflecting its pricing power and cost economics. The operating margin of 11.79 and net profit margin of 6.91 provide insight into operational efficiency.

Gross Margin47.47
Operating Margin11.79
Pretax Margin9.03
Profit Margin6.91
EBITDA Margin9.09

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Winner Medical Co. Ltd. Class A paid dividends of 0.82 per share. The dividend payout ratio of 55.13 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 3.27, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Winner Medical Co. Ltd. Class A shareholders.

Dividend Per Share0.82
Payout Ratio55.13
Shareholder Yield3.27

Stock Splits

Winner Medical Co. Ltd. Class A's most recent stock split took place on June 2, 2023 with a 5:7 split ratio.

Last Split Date6/2/2023
Split Ratio5:7

Scores

As of September 30, 2026, Winner Medical Co. Ltd. Class A has an Altman Z-Score of 3.41, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.41